## EquityIncentivePlansTables

**Year Ended**

|  | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| --- | --- | --- | --- |
| **  Share-Based Payment Arrangement, Activity** | The following table summarizes our stock option and RSU activity for the year 
ended December 31, 2024:

                                                       Stock Options            
RSUs              
                                                           Number of      
Weighted-         Weighted-                          Number              
  Beginning of period                                        344,021         
$35.11                                            19,088      225.01  
  Granted                                                     14,979        
$235.22                                            12,045      223.98  
  Exercised or released                                     (10,469)         
$82.04                                           (7,515)      206.02  
  Cancelled                                                  (3,996)        
$205.61                                           (4,957)      221.15  
  End of period                                              344,535         
$40.41              3.51      125.22              18,661      233.02  
  Vested and expected to vest, December 31, 2024             344,215         
$40.23              3.50      125.16              18,409      232.99  
  Exercisable and vested, December 31, 2024                  323,847         
$27.75              3.14      121.79
 |  |  |
| **  Schedule Of Share Based Payment Award Stock Options And Employee Stock Purchase Plan Valuation Assumptions** | The weighted-average assumptions used in the Black-Scholes model for stock 
options are as follows:

                                       Year Ended December 31,                  
                                                          2024      2023      
2022  
 ───────────────────────────────────────────────────────────────────────────────
─────
  Risk-free interest rate                                 3.92      3.90      
3.11  
  Expected term (in years)                                 4.3       4.5       
4.1  
  Expected volatility                                       59        63        
63  
  Dividend yield                                           0.0       0.0       
0.0  
  Grant date fair value per share                            $         $        
$
 |  |  |
| **  Summary of Stock-Based Compensation Expense** | The following table summarizes our stock-based compensation expense by line item
in the consolidated statements of operations (in millions):

                                           Year Ended December 31,              
                                           2024                                 
2023                 2022             
 ───────────────────────────────────────────────────────────────────────────────
──────────────────────────────────────────
  Cost of revenues                         $                              776   
$         741        $         594    
  Research and development                 832                                  
689                  536              
  Selling, general and administrative      389                                  
382                  430              
  Restructuring and other                  $                                2   
$         —          $         —      
  Total                                    $                            1,999   
$         1,812      $         1,560
 |  |  |